{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T10:05:52Z","timestamp":1772445952367,"version":"3.50.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T00:00:00Z","timestamp":1768608000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province","award":["2022E1002"],"award-info":[{"award-number":["2022E1002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"DOI":"10.1186\/s12866-025-04701-1","type":"journal-article","created":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T06:04:18Z","timestamp":1768629858000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The antiparasitic drug Nitazoxanide enhances the susceptibility of Candida albicans to fluconazole"],"prefix":"10.1186","volume":"26","author":[{"given":"Juan","family":"Pan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuocheng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panjie","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lulu","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beibei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiyi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tieli","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,17]]},"reference":[{"issue":"1","key":"4701_CR1","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1186\/s12951-024-02841-6","volume":"22","author":"Y Gao","year":"2024","unstructured":"Gao Y, Cao Q, Xiao Y, Wu Y, Ding L, Huang H, et al. The progress and future of the treatment of Candida albicans infections based on nanotechnology. J Nanobiotechnol. 2024;22(1):568. https:\/\/doi.org\/10.1186\/s12951-024-02841-6.","journal-title":"J Nanobiotechnol"},{"issue":"2","key":"4701_CR2","doi-asserted-by":"publisher","first-page":"e13250","DOI":"10.1111\/tid.13250","volume":"22","author":"SM Hosseini-Moghaddam","year":"2020","unstructured":"Hosseini-Moghaddam SM, Ou\u00e9draogo A, Naylor KL, Bota SE, Husain S, Nash DM, et al. Incidence and outcomes of invasive fungal infection among solid organ transplant recipients: A population-based cohort study. Transpl Infect Dis. 2020;22(2):e13250. https:\/\/doi.org\/10.1111\/tid.13250.","journal-title":"Transpl Infect Dis"},{"issue":"7","key":"4701_CR3","doi-asserted-by":"publisher","first-page":"e428","DOI":"10.1016\/S1473-3099(23)00692-8","volume":"24","author":"DW Denning","year":"2024","unstructured":"Denning DW. Global incidence and mortality of severe fungal disease. Lancet Infect Dis. 2024;24(7):e428\u201338. https:\/\/doi.org\/10.1016\/S1473-3099(23)00692-8.","journal-title":"Lancet Infect Dis"},{"key":"4701_CR4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.trsl.2022.04.002","volume":"247","author":"N-N Liu","year":"2022","unstructured":"Liu N-N, Zhou J, Jiang T, Tarsio M, Yu F, Zheng X, et al. A dual action small molecule enhances Azoles and overcomes resistance through co-targeting Pdr5 and Vma1. Transl Res. 2022;247:39\u201357. https:\/\/doi.org\/10.1016\/j.trsl.2022.04.002.","journal-title":"Transl Res"},{"key":"4701_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2024.03.006","author":"L Kriegl","year":"2024","unstructured":"Kriegl L, Egger M, Boyer J, Hoenigl M, Krause R. New treatment options for critically important WHO fungal priority pathogens. Clin Microbiol Infect. 2024. https:\/\/doi.org\/10.1016\/j.cmi.2024.03.006.","journal-title":"Clin Microbiol Infect"},{"key":"4701_CR6","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/j.biopha.2017.11.127","volume":"96","author":"B Sawant","year":"2017","unstructured":"Sawant B, Khan T. Recent advances in delivery of antifungal agents for therapeutic management of candidiasis. Biomed Pharmacother. 2017;96:1478\u201390. https:\/\/doi.org\/10.1016\/j.biopha.2017.11.127.","journal-title":"Biomed Pharmacother"},{"issue":"9","key":"4701_CR7","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41579-022-00720-1","volume":"20","author":"MC Fisher","year":"2022","unstructured":"Fisher MC, Alastruey-Izquierdo A, Berman J, Bicanic T, Bignell EM, Bowyer P, et al. Tackling the emerging threat of antifungal resistance to human health. Nat Rev Microbiol. 2022;20(9):557\u201371. https:\/\/doi.org\/10.1038\/s41579-022-00720-1.","journal-title":"Nat Rev Microbiol"},{"key":"4701_CR8","doi-asserted-by":"publisher","unstructured":"Donnelly RF, McCarron PA, Tunney MM. Antifungal photodynamic therapy. Microbiol Res. 2008;163(1). https:\/\/doi.org\/10.1016\/j.micres.2007.08.001.","DOI":"10.1016\/j.micres.2007.08.001"},{"key":"4701_CR9","doi-asserted-by":"publisher","unstructured":"Adaszy\u0144ska-Skwirzy\u0144ska M, Dzi\u0119cio\u0142 M, Szczerbi\u0144ska D. Lavandula angustifolia essential oils as effective enhancers of fluconazole antifungal activity against Candida albicans. Molecules. 2023;28(3). https:\/\/doi.org\/10.3390\/molecules28031176.","DOI":"10.3390\/molecules28031176"},{"issue":"8","key":"4701_CR10","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1016\/j.apsb.2021.04.010","volume":"11","author":"X Wang","year":"2021","unstructured":"Wang X, Mohammad IS, Fan L, Zhao Z, Nurunnabi M, Sallam MA, et al. Delivery strategies of amphotericin B for invasive fungal infections. Acta Pharm Sin B. 2021;11(8):2585\u2013604. https:\/\/doi.org\/10.1016\/j.apsb.2021.04.010.","journal-title":"Acta Pharm Sin B"},{"issue":"7\u20138","key":"4701_CR11","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1345\/aph.1R020","volume":"46","author":"ND Beyda","year":"2012","unstructured":"Beyda ND, Lewis RE, Garey KW. Echinocandin resistance in Candida species: mechanisms of reduced susceptibility and therapeutic approaches. Ann Pharmacother. 2012;46(7\u20138):1086\u201396. https:\/\/doi.org\/10.1345\/aph.1R020.","journal-title":"Ann Pharmacother"},{"key":"4701_CR12","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.3389\/fmicb.2015.01391","volume":"6","author":"S Patil","year":"2015","unstructured":"Patil S, Rao RS, Majumdar B, Anil S. Clinical appearance of oral Candida infection and therapeutic strategies. Front Microbiol. 2015;6:1391. https:\/\/doi.org\/10.3389\/fmicb.2015.01391.","journal-title":"Front Microbiol"},{"key":"4701_CR13","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.3389\/fmicb.2018.01351","volume":"9","author":"GC de Oliveira Santos","year":"2018","unstructured":"de Oliveira Santos GC, Vasconcelos CC, Lopes AJO, de Sousa Cart\u00e1genes MS, Filho AKDB, do Nascimento FRF, et al. Candida infections and therapeutic strategies: mechanisms of action for traditional and alternative agents. Front Microbiol. 2018;9:1351. https:\/\/doi.org\/10.3389\/fmicb.2018.01351.","journal-title":"Front Microbiol"},{"key":"4701_CR14","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.micpath.2018.02.028","volume":"117","author":"M Dadar","year":"2018","unstructured":"Dadar M, Tiwari R, Karthik K, Chakraborty S, Shahali Y, Dhama K. Candida albicans - Biology, molecular characterization, pathogenicity, and advances in diagnosis and control - An update. Microb Pathog. 2018;117:128\u201338. https:\/\/doi.org\/10.1016\/j.micpath.2018.02.028.","journal-title":"Microb Pathog"},{"key":"4701_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.phymed.2017.12.033","volume":"40","author":"L Sun","year":"2018","unstructured":"Sun L, Liao K, Hang C. Caffeic acid phenethyl ester synergistically enhances the antifungal activity of fluconazole against resistant Candida albicans. Phytomedicine. 2018;40:55\u20138. https:\/\/doi.org\/10.1016\/j.phymed.2017.12.033.","journal-title":"Phytomedicine"},{"issue":"10","key":"4701_CR16","doi-asserted-by":"publisher","first-page":"e1006405","DOI":"10.1371\/journal.pgen.1006405","volume":"12","author":"JL Xie","year":"2016","unstructured":"Xie JL, Grahl N, Sless T, Leach MD, Kim SH, Hogan DA, et al. Signaling through Lrg1, Rho1 and Pkc1 governs Candida albicans morphogenesis in response to diverse cues. PLoS Genet. 2016;12(10):e1006405. https:\/\/doi.org\/10.1371\/journal.pgen.1006405.","journal-title":"PLoS Genet"},{"issue":"3","key":"4701_CR17","doi-asserted-by":"publisher","first-page":"106394","DOI":"10.1016\/j.ijantimicag.2021.106394","volume":"58","author":"C Zhu","year":"2021","unstructured":"Zhu C, Liao B, Ye X, Zhou Y, Chen X, Liao M, et al. Artemisinin elevates ergosterol levels of Candida albicans to synergise with amphotericin B against oral candidiasis. Int J Antimicrob Agents. 2021;58(3):106394. https:\/\/doi.org\/10.1016\/j.ijantimicag.2021.106394.","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"4701_CR18","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.bbrc.2019.08.053","volume":"518","author":"SN Khan","year":"2019","unstructured":"Khan SN, Khan S, Misba L, Sharief M, Hashmi A, Khan AU. Synergistic fungicidal activity with low doses of Eugenol and amphotericin B against Candida albicans. Biochem Biophys Res Commun. 2019;518(3):459\u201364. https:\/\/doi.org\/10.1016\/j.bbrc.2019.08.053.","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"4701_CR19","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1038\/s41396-020-0679-2","volume":"14","author":"Y Wang","year":"2020","unstructured":"Wang Y, Lu J, Engelst\u00e4dter J, Zhang S, Ding P, Mao L, et al. Non-antibiotic pharmaceuticals enhance the transmission of exogenous antibiotic resistance genes through bacterial transformation. ISME J. 2020;14(8):2179\u201396. https:\/\/doi.org\/10.1038\/s41396-020-0679-2.","journal-title":"ISME J"},{"issue":"1","key":"4701_CR20","doi-asserted-by":"publisher","first-page":"105804","DOI":"10.1016\/j.ijantimicag.2019.09.008","volume":"55","author":"M Zhang","year":"2020","unstructured":"Zhang M, Yan H, Lu M, Wang D, Sun S. Antifungal activity of ribavirin used alone or in combination with fluconazole against Candida albicans is mediated by reduced virulence. Int J Antimicrob Agents. 2020;55(1):105804. https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.09.008.","journal-title":"Int J Antimicrob Agents"},{"key":"4701_CR21","doi-asserted-by":"publisher","unstructured":"Montoya MC, Beattie S, Alden KM, Krysan DJ. Derivatives of the antimalarial drug mefloquine are Broad-Spectrum antifungal molecules with activity against drug-Resistant clinical isolates. Antimicrob Agents Chemother. 2020;64(3). https:\/\/doi.org\/10.1128\/AAC.02331-19.","DOI":"10.1128\/AAC.02331-19"},{"issue":"2","key":"4701_CR22","doi-asserted-by":"publisher","first-page":"167","DOI":"10.2323\/jgam.59.167","volume":"59","author":"RB Shinde","year":"2013","unstructured":"Shinde RB, Rajput SB, Raut JS, Karuppayil SM. An in vitro repositioning study reveals antifungal potential of chloroquine to inhibit growth and morphogenesis in Candida albicans. J Gen Appl Microbiol. 2013;59(2):167\u201370. https:\/\/doi.org\/10.2323\/jgam.59.167.","journal-title":"J Gen Appl Microbiol"},{"issue":"4","key":"4701_CR23","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.bjid.2012.11.002","volume":"17","author":"RB Shinde","year":"2013","unstructured":"Shinde RB, Raut JS, Chauhan NM, Karuppayil SM. Chloroquine sensitizes biofilms of Candida albicans to antifungal Azoles. Braz J Infect Dis. 2013;17(4):395\u2013400. https:\/\/doi.org\/10.1016\/j.bjid.2012.11.002.","journal-title":"Braz J Infect Dis"},{"issue":"6","key":"4701_CR24","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.mib.2008.09.018","volume":"11","author":"NM Cooney","year":"2008","unstructured":"Cooney NM, Klein BS. Fungal adaptation to the mammalian host: it is a new world, after all. Curr Opin Microbiol. 2008;11(6):511\u20136. https:\/\/doi.org\/10.1016\/j.mib.2008.09.018.","journal-title":"Curr Opin Microbiol"},{"issue":"1","key":"4701_CR25","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","volume":"18","author":"S Pushpakom","year":"2019","unstructured":"Pushpakom S, Iorio F, Eyers PA, Escott KJ, Hopper S, Wells A, et al. Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov. 2019;18(1):41\u201358. https:\/\/doi.org\/10.1038\/nrd.2018.168.","journal-title":"Nat Rev Drug Discov"},{"issue":"9343","key":"4701_CR26","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/S0140-6736(02)11401-2","volume":"360","author":"B Amadi","year":"2002","unstructured":"Amadi B, Mwiya M, Musuku J, Watuka A, Sianongo S, Ayoub A, et al. Effect of Nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial. Lancet. 2002;360(9343):1375\u201380. https:\/\/doi.org\/10.1016\/S0140-6736(02)11401-2.","journal-title":"Lancet"},{"issue":"1","key":"4701_CR27","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.antiviral.2007.08.005","volume":"77","author":"BE Korba","year":"2008","unstructured":"Korba BE, Montero AB, Farrar K, Gaye K, Mukerjee S, Ayers MS, et al. Nitazoxanide, Tizoxanide and other thiazolides are potent inhibitors of hepatitis B virus and hepatitis C virus replication. Antiviral Res. 2008;77(1):56\u201363. https:\/\/doi.org\/10.1016\/j.antiviral.2007.08.005.","journal-title":"Antiviral Res"},{"issue":"7","key":"4701_CR28","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1128\/AAC.00901-09","volume":"54","author":"F Tchouaffi-Nana","year":"2010","unstructured":"Tchouaffi-Nana F, Ballard TE, Cary CH, Macdonald TL, Sifri CD, Hoffman PS. Nitazoxanide inhibits biofilm formation by Staphylococcus epidermidis by blocking accumulation on surfaces. Antimicrob Agents Chemother. 2010;54(7):2767\u201374. https:\/\/doi.org\/10.1128\/AAC.00901-09.","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"4701_CR29","doi-asserted-by":"publisher","first-page":"e0019124","DOI":"10.1128\/spectrum.00191-24","volume":"12","author":"X Jiang","year":"2024","unstructured":"Jiang X, Chen D, Wang X, Wang C, Zheng H, Ye W, et al. Nitazoxanide synergizes polymyxin B against Escherichia coli by depleting cellular energy. Microbiol Spectr. 2024;12(8):e0019124. https:\/\/doi.org\/10.1128\/spectrum.00191-24.","journal-title":"Microbiol Spectr"},{"issue":"19","key":"4701_CR30","doi-asserted-by":"publisher","first-page":"5789","DOI":"10.1021\/jm9010719","volume":"52","author":"LPS de Carvalho","year":"2009","unstructured":"de Carvalho LPS, Lin G, Jiang X, Nathan C. Nitazoxanide kills replicating and nonreplicating Mycobacterium tuberculosis and evades resistance. J Med Chem. 2009;52(19):5789\u201392. https:\/\/doi.org\/10.1021\/jm9010719.","journal-title":"J Med Chem"},{"key":"4701_CR31","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.biochi.2025.02.006","volume":"233","author":"W Li","year":"2025","unstructured":"Li W, Ji B, Li B, Du M, Wang L, Tuo J, et al. Nitazoxanide inhibits pili assembly by targeting bamb to synergize with polymyxin B against drug-resistant Escherichia coli. Biochimie. 2025;233:47\u201359. https:\/\/doi.org\/10.1016\/j.biochi.2025.02.006.","journal-title":"Biochimie"},{"key":"4701_CR32","doi-asserted-by":"publisher","unstructured":"Zhou Y, Huang X, Zhang W, Ji Y, Chen R, Xiong Y. Multi-branched gold nanoflower-embedded iron porphyrin for colorimetric immunosensor. Biosens Bioelectron. 2018;102. https:\/\/doi.org\/10.1016\/j.bios.2017.10.046.","DOI":"10.1016\/j.bios.2017.10.046"},{"issue":"6","key":"4701_CR33","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1007\/s00253-013-5425-5","volume":"98","author":"B Ren","year":"2014","unstructured":"Ren B, Dai H-Q, Pei G, Tong Y-J, Zhuo Y, Yang N, et al. ABC transporters coupled with the elevated ergosterol contents contribute to the Azole resistance and amphotericin B susceptibility. Appl Microbiol Biotechnol. 2014;98(6):2609\u201316. https:\/\/doi.org\/10.1007\/s00253-013-5425-5.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"2","key":"4701_CR34","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1093\/jac\/49.2.345","volume":"49","author":"RE Lewis","year":"2002","unstructured":"Lewis RE, Diekema DJ, Messer SA, Pfaller MA, Klepser ME. Comparison of Etest, chequerboard Dilution and time-kill studies for the detection of synergy or antagonism between antifungal agents tested against Candida species. J Antimicrob Chemother. 2002;49(2):345\u201351. https:\/\/doi.org\/10.1093\/jac\/49.2.345.","journal-title":"J Antimicrob Chemother"},{"key":"4701_CR35","doi-asserted-by":"publisher","unstructured":"Behbehani JM, Irshad M, Shreaz S, Karched M. Anticandidal activity of capsaicin and its effect on ergosterol biosynthesis and membrane integrity of Candida albicans. Int J Mol Sci. 2023;24(2). https:\/\/doi.org\/10.3390\/ijms24021046.","DOI":"10.3390\/ijms24021046"},{"issue":"9","key":"4701_CR36","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1128\/AAC.44.9.2373-2381.2000","volume":"44","author":"O Marchetti","year":"2000","unstructured":"Marchetti O, Moreillon P, Glauser MP, Bille J, Sanglard D. Potent synergism of the combination of fluconazole and cyclosporine in Candida albicans. Antimicrob Agents Chemother. 2000;44(9):2373\u201381. https:\/\/doi.org\/10.1128\/AAC.44.9.2373-2381.2000.","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"4701_CR37","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.cmi.2020.03.007","volume":"26","author":"P Wistrand-Yuen","year":"2020","unstructured":"Wistrand-Yuen P, Olsson A, Skarp KP, Friberg LE, Nielsen EI, Lagerb\u00e4ck P, et al. Evaluation of polymyxin B in combination with 13 other antibiotics against carbapenemase-producing Klebsiella pneumoniae in time-lapse microscopy and time-kill experiments. Clin Microbiol Infect. 2020;26(9):1214\u201321. https:\/\/doi.org\/10.1016\/j.cmi.2020.03.007.","journal-title":"Clin Microbiol Infect"},{"key":"4701_CR38","doi-asserted-by":"publisher","first-page":"789","DOI":"10.3389\/fmicb.2019.00789","volume":"10","author":"C-C Chen","year":"2019","unstructured":"Chen C-C, Lai C-C, Huang H-L, Huang W-Y, Toh H-S, Weng T-C, et al. Antimicrobial activity of Lactobacillus species against Carbapenem-Resistant Enterobacteriaceae. Front Microbiol. 2019;10:789. https:\/\/doi.org\/10.3389\/fmicb.2019.00789.","journal-title":"Front Microbiol"},{"issue":"2","key":"4701_CR39","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.jep.2012.01.029","volume":"140","author":"A Palmeira-de-Oliveira","year":"2012","unstructured":"Palmeira-de-Oliveira A, Gaspar C, Palmeira-de-Oliveira R, Silva-Dias A, Salgueiro L, Cavaleiro C, et al. The anti-Candida activity of thymbra capitata essential oil: effect upon pre-formed biofilm. J Ethnopharmacol. 2012;140(2):379\u201383. https:\/\/doi.org\/10.1016\/j.jep.2012.01.029.","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"4701_CR40","doi-asserted-by":"publisher","first-page":"2045813","DOI":"10.1080\/20002297.2022.2045813","volume":"14","author":"K Miranda-Cadena","year":"2022","unstructured":"Miranda-Cadena K, Marcos-Arias C, Perez-Rodriguez A, Cabello-Beitia I, Mateo E, Sevillano E, et al. In vitro and in vivo anti-Candida activity of Citral in combination with fluconazole. J Oral Microbiol. 2022;14(1):2045813. https:\/\/doi.org\/10.1080\/20002297.2022.2045813.","journal-title":"J Oral Microbiol"},{"key":"4701_CR41","doi-asserted-by":"publisher","first-page":"122767","DOI":"10.1016\/j.lfs.2024.122767","volume":"350","author":"K Zou","year":"2024","unstructured":"Zou K, Yin K, Ren S, Zhang R, Zhang L, Zhao Y, et al. Activity and mechanism of action of antimicrobial peptide acps against Candida albicans. Life Sci. 2024;350:122767. https:\/\/doi.org\/10.1016\/j.lfs.2024.122767.","journal-title":"Life Sci"},{"issue":"1","key":"4701_CR42","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1080\/14787210.2020.1811684","volume":"19","author":"X Chen","year":"2021","unstructured":"Chen X, Shi Y, Li Y, Su S, Wang P, Sun S. Antifungal effects and potential mechanisms of Lonidamine in combination with fluconazole against Candida albicans. Expert Rev Anti Infect Ther. 2021;19(1):109\u201315. https:\/\/doi.org\/10.1080\/14787210.2020.1811684.","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"1","key":"4701_CR43","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12866-022-02629-4","volume":"22","author":"T Guo","year":"2022","unstructured":"Guo T, Sun X, Yang J, Yang L, Li M, Wang Y, et al. Metformin reverse Minocycline to inhibit Minocycline-resistant acinetobacter baumannii by destroy the outer membrane and enhance membrane potential in vitro. BMC Microbiol. 2022;22(1):215. https:\/\/doi.org\/10.1186\/s12866-022-02629-4.","journal-title":"BMC Microbiol"},{"issue":"6","key":"4701_CR44","doi-asserted-by":"publisher","first-page":"106809","DOI":"10.1016\/j.isci.2023.106809","volume":"26","author":"J Cai","year":"2023","unstructured":"Cai J, Deng T, Shi J, Chen C, Wang Z, Liu Y. Daunorubicin resensitizes Gram-negative superbugs to the last-line antibiotics and prevents the transmission of antibiotic resistance. iScience. 2023;26(6):106809. https:\/\/doi.org\/10.1016\/j.isci.2023.106809.","journal-title":"iScience"},{"issue":"12","key":"4701_CR45","doi-asserted-by":"publisher","first-page":"3312","DOI":"10.1093\/jac\/dkac319","volume":"77","author":"W Zhang","year":"2022","unstructured":"Zhang W, Ran J, Shang L, Zhang L, Wang M, Fei C, et al. Niclosamide as a repurposing drug against Gram-positive bacterial infections. J Antimicrob Chemother. 2022;77(12):3312\u201320. https:\/\/doi.org\/10.1093\/jac\/dkac319.","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"4701_CR46","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1016\/j.biochi.2013.06.019","volume":"95","author":"JH Hwang","year":"2013","unstructured":"Hwang JH, Jin Q, Woo E-R, Lee DG. Antifungal property of hibicuslide C and its membrane-active mechanism in Candida albicans. Biochimie. 2013;95(10):1917\u201322. https:\/\/doi.org\/10.1016\/j.biochi.2013.06.019.","journal-title":"Biochimie"},{"key":"4701_CR47","doi-asserted-by":"publisher","first-page":"1455123","DOI":"10.3389\/fcimb.2025.1455123","volume":"15","author":"X Li","year":"2025","unstructured":"Li X, Zhi Y, Duan X, Chen X, Cui M, Zheng S. Synergistic antifungal effects and mechanisms of amantadine hydrochloride combined with Azole antifungal drugs on drug-resistant Candida albicans. Front Cell Infect Microbiol. 2025;15:1455123. https:\/\/doi.org\/10.3389\/fcimb.2025.1455123.","journal-title":"Front Cell Infect Microbiol"},{"issue":"12","key":"4701_CR48","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.4155\/fmc-2016-0050","volume":"8","author":"AR Holmes","year":"2016","unstructured":"Holmes AR, Cardno TS, Strouse JJ, Ivnitski-Steele I, Keniya MV, Lackovic K, et al. Targeting efflux pumps to overcome antifungal drug resistance. Future Med Chem. 2016;8(12):1485\u2013501. https:\/\/doi.org\/10.4155\/fmc-2016-0050.","journal-title":"Future Med Chem"},{"issue":"11","key":"4701_CR49","doi-asserted-by":"publisher","first-page":"3851","DOI":"10.1128\/AAC.00463-08","volume":"52","author":"AR Holmes","year":"2008","unstructured":"Holmes AR, Lin Y-H, Niimi K, Lamping E, Keniya M, Niimi M, et al. ABC transporter Cdr1p contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant Candida albicans clinical isolates. Antimicrob Agents Chemother. 2008;52(11):3851\u201362. https:\/\/doi.org\/10.1128\/AAC.00463-08.","journal-title":"Antimicrob Agents Chemother"},{"key":"4701_CR50","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.3389\/fmicb.2019.01085","volume":"10","author":"Y Yan","year":"2019","unstructured":"Yan Y, Tan F, Miao H, Wang H, Cao Y. Effect of Shikonin against Candida albicans biofilms. Front Microbiol. 2019;10:1085. https:\/\/doi.org\/10.3389\/fmicb.2019.01085.","journal-title":"Front Microbiol"},{"key":"4701_CR51","doi-asserted-by":"publisher","first-page":"790220","DOI":"10.3389\/fmicb.2021.790220","volume":"12","author":"X Zhang","year":"2021","unstructured":"Zhang X, Zhao Y, Feng L, Xu M, Ge Y, Wang L, et al. Combined with Mefloquine, resurrect colistin active in colistin-Resistant Pseudomonas aeruginosa in vitro and in vivo. Front Microbiol. 2021;12:790220. https:\/\/doi.org\/10.3389\/fmicb.2021.790220.","journal-title":"Front Microbiol"},{"issue":"4","key":"4701_CR52","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1080\/19490976.2017.1293225","volume":"8","author":"S Barnoy","year":"2017","unstructured":"Barnoy S, Gancz H, Zhu Y, Honnold CL, Zurawski DV, Venkatesan MM. The galleria Mellonella larvae as an in vivo model for evaluation of Shigella virulence. Gut Microbes. 2017;8(4):335\u201350. https:\/\/doi.org\/10.1080\/19490976.2017.1293225.","journal-title":"Gut Microbes"},{"issue":"5","key":"4701_CR53","doi-asserted-by":"publisher","first-page":"e259565","DOI":"10.1001\/jamanetworkopen.2025.9565","volume":"8","author":"J Henderson","year":"2025","unstructured":"Henderson J, Szatmari P, Cleverley K, Ma C, Hawke LD, Cheung A, et al. Integrated collaborative care for youths with mental health and substance use challenges: A randomized clinical trial. JAMA Netw Open. 2025;8(5):e259565. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.9565.","journal-title":"JAMA Netw Open"},{"issue":"4","key":"4701_CR54","doi-asserted-by":"publisher","first-page":"e70002","DOI":"10.1002\/jcsm.70002","volume":"16","author":"X Wu","year":"2025","unstructured":"Wu X, Liu R, Zhu N, Wang X, Wei C, An X, et al. Exogenous nucleotides supplementation attenuates Age-Related sarcopenia. J Cachexia Sarcopenia Muscle. 2025;16(4):e70002. https:\/\/doi.org\/10.1002\/jcsm.70002.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"4701_CR55","doi-asserted-by":"publisher","unstructured":"Naglik JR, Challacombe SJ, Hube B. Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol Mol Biol Rev. 2003;67(3). https:\/\/doi.org\/10.1128\/MMBR.67.3.400-428.2003.","DOI":"10.1128\/MMBR.67.3.400-428.2003"},{"key":"4701_CR56","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.biocel.2017.02.006","volume":"85","author":"J Tian","year":"2017","unstructured":"Tian J, Lu Z, Wang Y, Zhang M, Wang X, Tang X, et al. Nerol triggers mitochondrial dysfunction and disruption via elevation of Ca2\u2009+\u2009and ROS in Candida albicans. Int J Biochem Cell Biol. 2017;85:114\u201322. https:\/\/doi.org\/10.1016\/j.biocel.2017.02.006.","journal-title":"Int J Biochem Cell Biol"},{"key":"4701_CR57","doi-asserted-by":"publisher","unstructured":"Rybak JM, Doorley LA, Nishimoto AT, Barker KS, Palmer GE, Rogers PD. Abrogation of Triazole resistance upon deletion of CDR1 in a clinical isolate of Candida auris. Antimicrob Agents Chemother. 2019;63(4). https:\/\/doi.org\/10.1128\/AAC.00057-19.","DOI":"10.1128\/AAC.00057-19"},{"key":"4701_CR58","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.3389\/fmicb.2015.01382","volume":"6","author":"J Szczepaniak","year":"2015","unstructured":"Szczepaniak J, \u0141ukaszewicz M, Krasowska A. Estimation of Candida albicans ABC transporter behavior in Real-Time via fluorescence. Front Microbiol. 2015;6:1382. https:\/\/doi.org\/10.3389\/fmicb.2015.01382.","journal-title":"Front Microbiol"},{"issue":"10","key":"4701_CR59","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.7150\/thno.19680","volume":"7","author":"L Tan","year":"2017","unstructured":"Tan L, Peng J, Zhao Q, Zhang L, Tang X, Chen L, et al. A novel MPEG-PDLLA-PLL copolymer for docetaxel delivery in breast cancer therapy. Theranostics. 2017;7(10):2652\u201372. https:\/\/doi.org\/10.7150\/thno.19680.","journal-title":"Theranostics"},{"issue":"4","key":"4701_CR60","doi-asserted-by":"publisher","first-page":"e0047923","DOI":"10.1128\/mbio.00479-23","volume":"14","author":"PE Alabi","year":"2023","unstructured":"Alabi PE, Gautier C, Murphy TP, Gu X, Lepas M, Aimanianda V, et al. Small molecules restore Azole activity against drug-tolerant and drug-resistant Candida isolates. mBio. 2023;14(4):e0047923. https:\/\/doi.org\/10.1128\/mbio.00479-23.","journal-title":"mBio"},{"issue":"1","key":"4701_CR61","doi-asserted-by":"publisher","first-page":"e0229523","DOI":"10.1128\/spectrum.02295-23","volume":"12","author":"M Xu","year":"2024","unstructured":"Xu M, Yao Z, Kong J, Tang M, Liu Q, Zhang X, et al. Antiparasitic Nitazoxanide potentiates colistin against colistin-resistant acinetobacter baumannii and Escherichia coli in vitro and in vivo. Microbiol Spectr. 2024;12(1):e0229523. https:\/\/doi.org\/10.1128\/spectrum.02295-23.","journal-title":"Microbiol Spectr"},{"issue":"9","key":"4701_CR62","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1093\/jac\/dkac201","volume":"77","author":"G Kaul","year":"2022","unstructured":"Kaul G, Akhir A, Shukla M, Rawat KS, Sharma CP, Sangu KG, et al. Nitazoxanide potentiates linezolid against linezolid-resistant Staphylococcus aureus in vitro and in vivo. J Antimicrob Chemother. 2022;77(9):2456\u201360. https:\/\/doi.org\/10.1093\/jac\/dkac201.","journal-title":"J Antimicrob Chemother"},{"key":"4701_CR63","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.2147\/IJN.S400329","volume":"18","author":"Q-T Fu","year":"2023","unstructured":"Fu Q-T, Zhong X-Q, Chen M-Y, Gu J-Y, Zhao J, Yu D-H, et al. Luteolin-Loaded nanoparticles for the treatment of melanoma. Int J Nanomed. 2023;18:2053\u201368. https:\/\/doi.org\/10.2147\/IJN.S400329.","journal-title":"Int J Nanomed"},{"issue":"2","key":"4701_CR64","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ijantimicag.2012.10.009","volume":"41","author":"Q Yu","year":"2013","unstructured":"Yu Q, Ding X, Xu N, Cheng X, Qian K, Zhang B, et al. In vitro activity of verapamil alone and in combination with fluconazole or Tunicamycin against Candida albicans biofilms. Int J Antimicrob Agents. 2013;41(2):179\u201382. https:\/\/doi.org\/10.1016\/j.ijantimicag.2012.10.009.","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"4701_CR65","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1128\/AAC.04417-14","volume":"59","author":"Y Li","year":"2015","unstructured":"Li Y, Wan Z, Liu W, Li R. Synergistic activity of chloroquine with fluconazole against fluconazole-resistant isolates of Candida species. Antimicrob Agents Chemother. 2015;59(2):1365\u20139. https:\/\/doi.org\/10.1128\/AAC.04417-14.","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"4701_CR66","doi-asserted-by":"publisher","first-page":"5885","DOI":"10.1128\/AAC.00726-15","volume":"59","author":"X Li","year":"2015","unstructured":"Li X, Hou Y, Yue L, Liu S, Du J, Sun S. Potential targets for antifungal drug discovery based on growth and virulence in Candida albicans. Antimicrob Agents Chemother. 2015;59(10):5885\u201391. https:\/\/doi.org\/10.1128\/AAC.00726-15.","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"4701_CR67","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/j.bbamcr.2008.01.023","volume":"1783","author":"GG Perrone","year":"2008","unstructured":"Perrone GG, Tan S-X, Dawes IW. Reactive oxygen species and yeast apoptosis. Biochim Biophys Acta. 2008;1783(7):1354\u201368. https:\/\/doi.org\/10.1016\/j.bbamcr.2008.01.023.","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"4701_CR68","doi-asserted-by":"publisher","first-page":"5858","DOI":"10.1128\/AAC.01252-16","volume":"60","author":"S Bhattacharya","year":"2016","unstructured":"Bhattacharya S, Sobel JD, White TC. A combination fluorescence assay demonstrates increased efflux pump activity as a resistance mechanism in Azole-Resistant vaginal Candida albicans isolates. Antimicrob Agents Chemother. 2016;60(10):5858\u201366. https:\/\/doi.org\/10.1128\/AAC.01252-16.","journal-title":"Antimicrob Agents Chemother"},{"key":"4701_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2025.02.006","author":"W Li","year":"2025","unstructured":"Li W, Ji B, Li B, Du M, Wang L, Tuo J, et al. Nitazoxanide inhibits pili assembly by targeting bamb to synergize with polymyxin B in targeting drug-resistant Escherichia coli. Biochimie. 2025. https:\/\/doi.org\/10.1016\/j.biochi.2025.02.006.","journal-title":"Biochimie"},{"key":"4701_CR70","doi-asserted-by":"publisher","unstructured":"Suchodolski J, Muraszko J, Bernat P, Krasowska A. A crucial role for ergosterol in plasma membrane Composition, Localisation, and activity of Cdr1p and H+-ATPase in Candida albicans. Microorganisms. 2019;7(10). https:\/\/doi.org\/10.3390\/microorganisms7100378.","DOI":"10.3390\/microorganisms7100378"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-025-04701-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-04701-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-04701-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T09:22:21Z","timestamp":1772443341000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12866-025-04701-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,17]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4701"],"URL":"https:\/\/doi.org\/10.1186\/s12866-025-04701-1","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,17]]},"assertion":[{"value":"28 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee in Clinical Research of the First Affiliated Hospital of Wenzhou Medical University (KY2025-R401). Given the retrospective nature of this study, the Ethics Committee in Clinical Research of the First Affiliated Hospital of Wenzhou Medical University waived the requirement for informed consent. All clinical isolates used in the study were fully anonymized prior to experimental use\u2014all patient identifiers (e.g., name, medical record number, contact information) were removed to protect participant privacy. All procedures were conducted following the standards of our ethics committee and adhered to the tenets of the Declaration of Helsinki.Four-week-old male ICR mice of SPF grade were sourced from Vital River in Zhejiang, China. All surgical procedures involving mice were performed under general anesthesia to minimize animal suffering. Mice were intraperitoneal injection of pentobarbital sodium (50 mg\/kg) to achieve deeply anesthesia, as indicated by loss of consciousness and unresponsiveness to noxious stimuli (e.g., toe pinch). Euthanasia was then performed immediately via CO2 inhalation. All procedures involving mice were approved by the First Affiliated Hospital Ethics Committee of Wenzhou Medical University (Approval No. SYXK 2021-0017) and were carried out in accordance with the Wenzhou Laboratory Animal Welfare and Ethics Guidelines, as well as the NIH Guide for the Care and Use of Laboratory Animals.Galleria mellonella were purchased from Tianjin Huiyude Biotechnology Co., Ltd., China. According to Chinese regulations (Guidelines for Ethical Review of Laboratory Animal Welfare, GB\/T 35892-2018), ethical approval is not required for studies involving invertebrates. All experiments were designed to minimize suffering.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"178"}}